Search Results

You are looking at 101 - 110 of 434 items for :

  • All content x
Clear All
Full access

Linda Overholser and Carlin Callaway

unmet needs after treatment. Many patients have also suffered physical side effects and have seen the relationships in their lives undergo dramatic shifts. Patients’ needs often relate to quality of life (fatigue, fear of recurrence) and/or their ability

Full access

Javaughn Corey R. Gray, Jongho Kim, Michael Digianvittorio, Nancy K. Feeley, Paul J. Scheel, Stanley S. Siegelman, Elliot K. Fishman, and Steven P. Rowe

hypertension, chronic kidney disease, anemia, and pericardial effusion initially presented with severe fatigue, cognitive impairment, and diffuse bone pain. He also reported muscle pain in his thighs and calves, diminished appetite, and severe lethargy. In a

Full access

Jennifer A. Ligibel and Crystal S. Denlinger

.” Subtopics included in the Guidelines are anxiety and depression, cognitive function, exercise, immunizations/infections, fatigue, pain, sexual function, and sleep disorders. The select subtopics presented by Drs. Ligibel and Denlinger were exercise

Full access

Thomas Olencki

SCC. A phase II study was conducted at his center, but was discontinued due to overwhelming fatigue, anorexia, weight loss, and pleural effusion. Other therapies appear to offer more promise in the treatment of cutaneous SCC. Dr. Olencki discussed

Full access

David S. Ettinger

%, respectively. The most common side effects of nivolumab were fatigue, musculoskeletal pain, decreased appetite, cough, and constipation. Eighty-three patients had tumor samples suitable for PD-L1 expression analysis. Across the prespecified expression levels

Full access

Andrew J. Armstrong

men that were evaluated,” explained Dr. Armstrong. Fatigue, fall risk, and hypertension were the most common clinically relevant adverse events associated with enzalutamide treatment. 7 In fact, hypertension occurred 2 to 3 times as often with

Full access

Michelle E. Melisko and Joseph B. Narus

not so obvious ways,” stated Dr. Melisko. For instance, adverse effects of treatment may include reduced sexual desire, decreased libido, and fatigue. In addition, “Endocrine therapy has a profound impact on both men and women,” she added. Along with

Full access

Presenter: Stephen D. Smith

.4 months. The safety of ibrutinib in MZL is similar to that seen in other diseases. Frequently occurring adverse effects include fatigue, diarrhea, and anemia. Atrial fibrillation should be a reason for concern in patients with cardiac history, said Dr

Full access

-Ineligible, Newly Diagnosed Multiple Myeloma In the first case study, a 75-year-old man presented with new back pain and fatigue. The patient was able to perform all activities of daily living and resided approximately 70 miles away from the treatment center

Full access

Diane L. Reidy-Lagunes

administered at 37.5 mg daily (as opposed to the 50-mg dose in the phase II study) because of the increased rate of grade 3 fatigue discussed previously. 2 The study was stopped prematurely by the independent Data Monitoring Committee before the first